Skip to content
10-Q

Quarterly Report

CYCLO THERAPEUTICS, INC.

0001437749-24-017038

← back to feed
Filed
May 15, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 8, 2024 28.62M sh
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$6.18M
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$4.37M
Cash And Equivalents Q1 2024 · Mar 31, 2024 $3M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $9.25M
Stockholders Equity Q1 2024 · Mar 31, 2024 $610.01K
Stockholders Equity Q1 2024 · Dec 31, 2023 $4.76M
Stockholders Equity Q1 2024 · Mar 31, 2023 −$438.88K
Stockholders Equity Q1 2024 · Dec 31, 2022 $734.54K
Current Liabilities Q1 2024 · Mar 31, 2024 $6.54M
Current Liabilities Q1 2024 · Dec 31, 2023 $8.47M
Current Assets Q1 2024 · Mar 31, 2024 $6.57M
Current Assets Q1 2024 · Dec 31, 2023 $12.32M
Total Assets Q1 2024 · Mar 31, 2024 $7.16M
Total Assets Q1 2024 · Dec 31, 2023 $13.25M
Eps Basic Q1 2024 · Mar 31, 2024 −$0.15
Eps Basic Q1 2024 · Mar 31, 2023 −$0.46
Rd Expense Q1 2024 · Mar 31, 2024 $2.85M
Rd Expense Q1 2024 · Mar 31, 2023 $3.4M
Net Income Q1 2024 · Mar 31, 2024 −$4.34M
Net Income Q1 2024 · Mar 31, 2023 −$5.01M
Operating Income Q1 2024 · Mar 31, 2024 −$5.12M
Operating Income Q1 2024 · Mar 31, 2023 −$5.01M
Gross Profit Q1 2024 · Mar 31, 2024 $190.63K
Gross Profit Q1 2024 · Mar 31, 2023 $142.22K